48
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous

The Lyme disease controversies continue

Pages 1615-1620 | Published online: 02 Mar 2005

Bibliography

  • PAVIA CS: Current and novel therapies for Lyme disease. Expert Opin. Investig. Drugs (2003) 12(6):1003–1016.
  • ••Extensive and up-to-date review on various aspects of Lyme disease and its cause, with the emphasis on therapeutic options.
  • WALLACH FR, FORNI AL, HARIPRASHAD J et al: Circulating Borrelia burgdorferiin patients with acute Lyme disease: results of blood cultures and serum DNA analysis. J. Infect. Dis. (1993) 168:1541–1543.
  • GOODMAN JL, BRADLEY JF, ROSS AE et al: Bloodstream invasion in early Lyme disease: results from a prospective controlled, blinded study using the polymerase chain reaction. Am. J. Med. (1995) 99:6–12.
  • WORMSER GP, NOWAKOWSKI J, NADELMAN RB et al: Improving the yield of blood cultures for patients with early Lyme disease. j. Clio. Microbial. (1998) 36:296–298.
  • WORMSER GP, BITTKER S, COOPER D et al.: Yield of large-volume blood cultures in patients with early Lyme disease. J. Infect. Dis. (2001) 184:1070–1072.
  • •Isolation of Bb from the blood of patients can be enhanced using larger volumes of test sample.
  • AGUERO-ROSENFELD ME, NOWAKOWSKI J, BITTKER S et al.: Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clio. Microbial. (1996) 34:1–9.
  • PAVIA CS, WORMSER GP, BITTKER S, COOPER D: An indirect hemagglutination antibody test to detect antibodies to Borrelia burgdorferi in patients with Lyme disease. J. Microbial. Methods (2000) 40:163–173.
  • STEERE AC: Lyme disease. N Engl. Med. (2001) 345:115–125.
  • ••A detailed and recent review on Lyme disease, emphasising clinical aspects.
  • PREAC-MURSIC V, WANNER G, REINHARDT S: Formation and cultivation of Borrelia burgdorferi spheroplast L-form variants. Infection (1996) 24:218–226.
  • BRORSON 0, BRORSON SH: In vitro cultivation of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection (1998) 26:144–150.
  • ALBAN PS, JOHNSON PW, NELSON DR: Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi Microbiology (2000) 146:119–127.
  • SADZIENE A, JONSSON M, BERGSTROM S et al.: A bactericidal antibody to Borrelia burgdorferi is directed against variable region of the OspB protein. Infect. Inman. (1994) 62:2037–2045.
  • BARBOUR AG, TODD WJ, STOENNER HG: Action of penicillin on Borrelia hermsii. Antirnicrob. Agents Cbeinotber. (1982) 21:823–829.
  • •First description of blebs as a unique structural component of dying Borrelia.
  • PAVIA CS, WORMSER GP, NOWAKOWSK J, CACCIAPUOTI A: Efficacy of an evernimicin (5CH27899) in vitro and in an animal model of Lyme disease. Antimicrob. Agents Cbeinotber. (2001) 45:936–937.
  • PHILIPS SE, MATTMAN LH, HULINSKA D, MOAYAD H: A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those aggressively treated. Infection (1998) 26:364–367.
  • MARQUES AR, STOCK F, GILL V: Evaluation of a new culture medium for Borrelia burgdorferi I Clin. Microbial. (2000) 38:4239–4241.
  • •Failure to demonstrate any growth-promoting capabilities of MPM medium, as well as to confirm the isolation of Bb or so-called cyst forms from patient blood samples using MPM medium.
  • TILTON RC, BARDEN D, SAND M: Culture of Borrelia burgdorferi j Clio. Microbial. (2001) 39:2747.
  • JONES RH, FINN MA, THOMAS JJ, FOLGER C: Growth and subculture of pathogenic 7: pallid= (Nichols strain) in BHK-21 cultured tissue cells. Br. J. Vent.]: Dis. (1976) 52:18–23.
  • FOSTER JW, KELLOGG DS, CLARK JW, BALOWS A: The M vitro cultivation of Treponema palliduin Corroborative studies. Br. J. Vener: Dis. (1977) 53:338–339.
  • ANONYMOUS: LYMErix. Lack of demand kills Lyme disease vaccine. Nursing (2002) 32:18.
  • LATHROP SL, BALL R, HABER P et al: Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine (2002) 20: 1603-1608.
  • MAY, STURROCK A, WEISS JJ: Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect. Inman. (1991) 59:671–678.
  • KLEMPNER MS, NORING R, ROGERS RA: Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi J. Infect. Dis. (1993) 167:1074–1081.
  • LIANG FT, JACOBS MB, BOWERS LC, PHILIPP MT: An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. Expt. Med. (2002) 195:415–422.
  • PETERSON PK, CLAWSON CC, LEE DA et al: Human phagocyte interactions with the Lyme disease spirochete. Infect. Inman. (1984) 46:608–611.
  • TEREKHOVA D, SARTAKOVA ML WORMSER GP et al: Erythromycin resistance in Borrelia burgdorferi. Antimicrob. Agents Chemother: (2002) 46:3637–3640.
  • WORMSER GP, NADELMAN RB, DATTWYLER RL et al: Practice guidelines for the treatment of Lyme disease. Clin. Infect. Dis. (2000) 31\(Suppl. 1):1–14.
  • ••Reliable and comprehensive referencesource for treating Lyme disease authored by an expert physician panel.
  • KRAUSE PJ, TELFORD SR 3rd, SPIELMAN A et al.: Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA (1996) 275:1657–1660.
  • NADELMAN RB, NOWAKOWSKI J, FISH D et al.: Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularistick bite. N. Engl. J. Med. (2001) 345:79–84.
  • ••Large-scale study showing the effectivenessof single-dose therapy in preventing Lyme disease following a documented tick bite.
  • BARBOUR AG, FISH D: The biological and social phenomenon of Lyme disease. Science (1993) 260:1610–1616.
  • BELONGIA EA: Epidemiology and impact of coinfections acquired from Ixodes ticks. Vector Borne Zoonotic Dis. (2002) 2:265–273.
  • HILTON E, DE VOTI J, BENACH JL et al.: Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am. J. Med. (1999) 106:404–409.
  • KLEMPNER MS, LINDEN TH, EVANS J et al.: Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. (2001) 345:85–92.
  • ••Large-scale and well-controlled studyshowing the lack of any benefit of additional antibiotic treatment for authentic post-Lyme syndrome.
  • KAPLAN RE TREVINO RP, JOHNSON GM et al.: Cognitive function in post-treatment Lyme disease. Do additional antibiotics help? Neurology (2003) 60:1916–1922.
  • DUBOS R: Pasteur's first steps toward biology. In: Pasteur and Modern Science. T Brock (Ed.), ASM Press, Washington, DC (1998):25.
  • AFZELIUS A: Report to Verhandlungen der dermatologischen Gesellschaft zu Stockholm on December 16, 1909. Arch. Dermatol Syph. (1910) 101:405–406.
  • •First published report of an unusual skin rash as a clinical manifestation of a new syndrome, later called Lyme disease, and its possible association with a tick bite.
  • STEERE AC, MALAWISTA SE, SNYDMAN DR et al.: Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritic Rheum. (1977) 20:7–17.
  • •Initial clinical description of Lyme arthritis occurring in North America.
  • BURGDORFER W, BARBOUR AG, HAYES SF et al.: Lyme disease - a tick-borne spirochetosis? Science (1982) 216:1317–1321.
  • •First laboratory identification of the Lyme disease spirochete and its isolation from ticks.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.